
C
Tier
Topical Botox-like hexapeptide that relaxes expression lines.
Skin & Beauty
Peptide, 6 amino acids
WADA Status:
Not listed
Human Trial Scoreboard
Completed human RCTs
Count not verified
Largest Human Study
Size not verified
Longest exposure
Duration not verified
Most Recent Trial
Year not verified
Description
Argireline, properly acetyl hexapeptide-8, is a six amino acid cosmetic peptide. Its mechanism is often described as a topical alternative to botulinum toxin, and the underlying idea is loosely related: it is thought to interfere with the protein complex that helps nerve cells release the signal telling muscles to contract. The comparison collapses on contact with reality. Botulinum toxin is injected directly into muscle and blocks that signalling potently, while argireline is applied to the skin surface, where it must first cross a barrier specifically evolved to keep molecules out. The measurable effect is modest and the evidence comes largely from small cosmetic studies. It is a real ingredient with a real, small effect, sold under an oversized comparison.
What Are The Claims
Claims made for this compound: May soften fine lines and expression wrinkles (topical cosmetic data); Mild, reversible smoothing with consistent use; A non-invasive alternative concept to injectables
Evidence
Legitimate cosmetic category. Effects on expression lines in small studies are real but modest, and the frequent comparison to injectable neurotoxins overstates what a topical peptide does.
Evidence Strength
Preliminary (small cosmetic studies)
Caveats
Cosmetic ingredient only; not FDA-approved as a drug; no authorized medical use; no independent clinical trials confirming systemic effects.
Safety
Alternative Measures
Legal Status
US
Cosmetic ingredient only
UK
Cosmetic ingredient only
EU
Cosmetic ingredient only
AU
Cosmetic ingredient only
WADA
Not listed
Cosmetic ingredient for topical use. Not a drug.
Citations
Blanes-Mira et al. (2002). Int J Cosmet Sci. Small topical anti-wrinkle study.